What is the recommended treatment approach for trichotillomania in a patient with comorbid attention-deficit/hyperactivity disorder?

Treatment of Trichotillomania with Comorbid ADHD

The recommended approach is to treat the ADHD first with standard FDA-approved medications (methylphenidate or amphetamines as first-line), followed by evidence-based behavioral therapy (Habit Reversal Training) for the trichotillomania, as treating ADHD does not worsen trichotillomania severity and may improve impulse control. 1

Treatment Sequencing and Rationale

Prioritize ADHD Treatment First

• Begin with stimulant medication for ADHD using methylphenidate formulations or amphetamines as first-line pharmacological treatment, as these have the strongest evidence (effect size 1.0) and work in 70-80% of patients. 2, 3, 4

• The presence of comorbid trichotillomania should not alter your standard ADHD treatment approach—stimulants do not worsen trichotillomania severity despite historical case reports suggesting otherwise. 1

• If methylphenidate is chosen, start with long-acting formulations for better adherence and consistent symptom control throughout the day. 3

Address Trichotillomania Concurrently with Behavioral Interventions

• Implement Habit Reversal Training (HRT) as the evidence-based behavioral treatment for trichotillomania, which includes awareness training and competing response training to replace hair-pulling behaviors. 5

• Consider augmenting HRT with wearable vibration devices that provide real-time feedback when hair-pulling occurs, as this combination has shown effectiveness in naturalistic settings with comorbid ADHD patients. 5

• The behavioral intervention can be initiated alongside ADHD medication rather than waiting for ADHD symptom stabilization. 5

Clinical Considerations for This Comorbidity

Expected Outcomes

• Patients with both conditions demonstrate significantly higher impulsivity scores (attentional, motor, and non-planning impulsiveness) compared to those with trichotillomania alone. 1

• However, the comorbid ADHD does not affect trichotillomania severity, quality of life, or functional impairment—meaning both conditions can be treated independently without one worsening the other. 1

• Treating ADHD may indirectly benefit trichotillomania through improved executive function and impulse control. 3

Medication Selection Algorithm

First-line options:

• Methylphenidate (short, intermediate, or long-acting formulations) 2, 4
• Amphetamine preparations (short or long-acting) 2, 4

Second-line options if stimulants fail or are not tolerated:

• Atomoxetine (effect size 0.7, requires 2-12 weeks for full effect) 3, 4
• Extended-release guanfacine 3, 4
• Extended-release clonidine 3, 4

Important Caveats

• One case report documented Adderall-induced trichotillomania in a 12-year-old that resolved when switched to guanfacine, but this appears to be an extremely rare occurrence. 6

• A small study (n=9) showed methylphenidate improved ADHD symptoms but did not significantly change hair-pulling severity, though patients with fewer stressful life events showed some trichotillomania improvement. 7

• Screen for additional comorbidities including anxiety, depression, obsessive-compulsive disorder, and eating disorders (particularly bulimia nervosa), as these frequently co-occur and may require additional treatment modifications. 8

Pre-Treatment Requirements

• Assess for cardiac disease, substance abuse history, motor/verbal tics, and other psychiatric comorbidities before initiating stimulant therapy. 3

• Obtain detailed drug and alcohol use history with consideration of urine drug screen, as stimulant prescribing is contraindicated in active substance abuse. 3

• Document baseline trichotillomania severity using the Massachusetts General Hospital Hair-Pulling Scale to monitor for any changes. 7

Monitoring Strategy

• Use standardized ADHD rating scales (ADHD-RS, Conners Adult ADHD Rating Scale) to track core ADHD symptoms. 3

• Monitor trichotillomania frequency through daily self-reports or wearable device monitoring functions. 5

• Assess vital signs, functional outcomes, and screen for emerging anxiety or mood symptoms regularly. 3

• If trichotillomania worsens after stimulant initiation (rare), consider switching to non-stimulant options like atomoxetine or guanfacine rather than abandoning ADHD treatment entirely. 6